Dietary agents as histone deacetylase inhibitors: sulforaphane and structurally related isothiocyanates
Open Access
- 29 July 2008
- journal article
- review article
- Published by Oxford University Press (OUP)
- Vol. 66, S36-S38
- https://doi.org/10.1111/j.1753-4887.2008.00065.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Molecular basis for chemoprevention by sulforaphane: a comprehensive reviewCellular and Molecular Life Sciences, 2007
- Sulforaphane induces cell type–specific apoptosis in human breast cancer cell linesMolecular Cancer Therapeutics, 2007
- Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects.2007
- Phenylhexyl isothiocyanate inhibits histone deacetylases and remodels chromatins to induce growth arrest in human leukemia cellsInternational Journal of Oncology, 2006
- Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis inApcminmiceThe FASEB Journal, 2006
- Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cellsCarcinogenesis: Integrative Cancer Research, 2005
- Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention?Carcinogenesis: Integrative Cancer Research, 2005
- Chemoprotection by sulforaphane: Keep one eye beyond Keap1Cancer Letters, 2005
- Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-κB and pro-inflammatory gene expressionBiochemical Pharmacology, 2004
- A Novel Mechanism of Chemoprotection by SulforaphaneCancer Research, 2004